Insufficient scRNA-seq data for expression of NLRP9 at single-cell level.
Insufficient scRNA-seq data for expression of NLRP9 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 98% | 24.58 | 239 / 245 | 12% | 0.46 | 58 / 502 |
uterus | 92% | 11.42 | 156 / 170 | 0% | 0.00 | 1 / 459 |
intestine | 90% | 10.98 | 868 / 966 | 1% | 0.01 | 5 / 527 |
stomach | 86% | 8.31 | 309 / 359 | 3% | 0.04 | 9 / 286 |
bladder | 86% | 11.67 | 18 / 21 | 0% | 0.01 | 2 / 504 |
blood vessel | 83% | 6.83 | 1102 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 78% | 6.67 | 257 / 328 | 3% | 0.08 | 6 / 178 |
ovary | 73% | 21.76 | 132 / 180 | 0% | 0 | 0 / 430 |
esophagus | 70% | 5.51 | 1017 / 1445 | 2% | 0.05 | 3 / 183 |
kidney | 70% | 4.48 | 62 / 89 | 2% | 0.04 | 16 / 901 |
breast | 63% | 3.25 | 288 / 459 | 1% | 0.01 | 7 / 1118 |
spleen | 61% | 2.82 | 146 / 241 | 0% | 0 | 0 / 0 |
skin | 60% | 3.59 | 1087 / 1809 | 0% | 0.01 | 1 / 472 |
adipose | 56% | 2.86 | 676 / 1204 | 0% | 0 | 0 / 0 |
lung | 53% | 2.31 | 304 / 578 | 0% | 0.01 | 4 / 1155 |
brain | 51% | 2.58 | 1349 / 2642 | 0% | 0.01 | 2 / 705 |
adrenal gland | 49% | 2.03 | 126 / 258 | 0% | 0.01 | 1 / 230 |
thymus | 43% | 1.49 | 281 / 653 | 0% | 0.00 | 1 / 605 |
muscle | 37% | 1.24 | 297 / 803 | 0% | 0 | 0 / 0 |
liver | 34% | 1.18 | 76 / 226 | 1% | 0.02 | 3 / 406 |
heart | 24% | 0.68 | 204 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 23% | 0.71 | 211 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051607 | Biological process | defense response to virus |
GO_0070269 | Biological process | pyroptotic inflammatory response |
GO_0032741 | Biological process | positive regulation of interleukin-18 production |
GO_0006954 | Biological process | inflammatory response |
GO_0050727 | Biological process | regulation of inflammatory response |
GO_0045087 | Biological process | innate immune response |
GO_0061702 | Cellular component | canonical inflammasome complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NLRP9 |
Protein name | NACHT, LRR and PYD domains-containing protein 9 (Nucleotide-binding oligomerization domain protein 6) (PYRIN and NACHT-containing protein 12) |
Synonyms | PAN12 NOD6 NALP9 |
Description | FUNCTION: As the sensor component of the NLRP9 inflammasome, plays a crucial role in innate immunity and inflammation. In response to pathogens, including rotavirus, initiates the formation of the inflammasome polymeric complex, made of NLRP9, PYCARD and CASP1. Recruitment of proCASP1 to the inflammasome promotes its activation and CASP1-catalyzed IL1B and IL18 maturation and release in the extracellular milieu. The active cytokines stimulate inflammatory responses. Inflammasomes can also induce pyroptosis, an inflammatory form of programmed cell death. NLRP9 inflammasome activation may be initiated by DHX9 interaction with viral double-stranded RNA (dsRNA), preferentially to short dsRNA segments. . |
Accessions | ENST00000332836.7 [Q7RTR0-1] Q7RTR0 ENST00000590200.1 [Q7RTR0-2] |